Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003201456 | SCV003901658 | uncertain significance | Inborn genetic diseases | 2023-03-02 | criteria provided, single submitter | clinical testing | The c.1720G>A (p.E574K) alteration is located in exon 14 (coding exon 13) of the DIS3L2 gene. This alteration results from a G to A substitution at nucleotide position 1720, causing the glutamic acid (E) at amino acid position 574 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |